Development and estimation of an oro-dispersible anti-malarial dosage form for pediatric patient
School of Pharmacy, Dr. A.P. J. Abdul Kalam University, Indore, India.
Research Article
World Journal of Biology Pharmacy and Health Sciences, 2023, 13(01), 250-257.
Article DOI: 10.30574/wjbphs.2023.13.1.0029
Publication history:
Received on 03 December 2022; revised on 11 January 2023; accepted on 14 January 2023
Abstract:
Artemether-Lumefantrine tablets are inconvenient for caregivers to administer as they need to be crushed and mixed with water or food for infants and young children. Further, in common with other anti-malarial, they have a bitter taste, which may result in children spitting the medicine out and not receiving the full therapeutic dose. There was a clear unmet medical need for a formulation of AL specifically designed for children.
Keywords:
Oro-dispersible; Pediatric; Artemisinin; Lumefantrine; Malaria
Full text article in PDF:
Copyright information:
Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0